Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lopez

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|November 27, 2021
Predictors of Ascending Aorta Enlargement and Valvular Dysfunction Progression in Patients with Bicuspid Aortic ValveAngela Lopez, Ilaria Dentamaro, Laura Galian, et al.
BJU International|June 28, 2024
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapyAxel S Merseburger, Neeraj Agarwal, Anders Bjartell, et al.
The Journal of Urology|May 27, 2021
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN StudyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Scientific Reports|March 18, 2020
A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK ProjectDomingo Orozco-Beltran, Jose A Quesada, Vicente Bertomeu-Gonzalez, et al.
Scientific Reports|August 16, 2023
Author Correction: A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK ProjectDomingo Orozco-Beltran, Jose A Quesada, Vicente Bertomeu-Gonzalez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic DiseaseMatthew R Smith, Shibu Thomas, Michael Gormley, et al.
The Journal of Urology|July 23, 2021
Reply by AuthorsNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Plos Pathogens|May 26, 2017
Elevated catalase expression in a fungal pathogen is a double-edged sword of ironArnab Pradhan, Carmen Herrero-de-Dios, Rodrigo Belmonte, et al.
Journal of the American College of Cardiology|June 18, 2021
Aortic Branch Aneurysms and Vascular Risk in Patients With Marfan SyndromeAngela Lopez-Sainz, Laia Mila, Jose Rodriguez-Palomares, et al.
European Urology|September 10, 2020
Apalutamide and Overall Survival in Prostate CancerMatthew R Smith, Fred Saad, Simon Chowdhury, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|November 27, 2021
Predictors of Ascending Aorta Enlargement and Valvular Dysfunction Progression in Patients with Bicuspid Aortic ValveAngela Lopez, Ilaria Dentamaro, Laura Galian, et al.
BJU International|June 28, 2024
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapyAxel S Merseburger, Neeraj Agarwal, Anders Bjartell, et al.
The Journal of Urology|May 27, 2021
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN StudyNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Scientific Reports|March 18, 2020
A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK ProjectDomingo Orozco-Beltran, Jose A Quesada, Vicente Bertomeu-Gonzalez, et al.
Scientific Reports|August 16, 2023
Author Correction: A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK ProjectDomingo Orozco-Beltran, Jose A Quesada, Vicente Bertomeu-Gonzalez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic DiseaseMatthew R Smith, Shibu Thomas, Michael Gormley, et al.
The Journal of Urology|July 23, 2021
Reply by AuthorsNeeraj Agarwal, Kelly McQuarrie, Anders Bjartell, et al.
Plos Pathogens|May 26, 2017
Elevated catalase expression in a fungal pathogen is a double-edged sword of ironArnab Pradhan, Carmen Herrero-de-Dios, Rodrigo Belmonte, et al.
Journal of the American College of Cardiology|June 18, 2021
Aortic Branch Aneurysms and Vascular Risk in Patients With Marfan SyndromeAngela Lopez-Sainz, Laia Mila, Jose Rodriguez-Palomares, et al.
European Urology|September 10, 2020
Apalutamide and Overall Survival in Prostate CancerMatthew R Smith, Fred Saad, Simon Chowdhury, et al.
Pageof 8